Skip to main content
Top
Published in: BMC Infectious Diseases 1/2010

Open Access 01-12-2010 | Research article

The burden and characteristics of tuberculosis/human immunodeficiency virus (TB/HIV) in South Korea: a study from a population database and a survey

Authors: Chang-Hoon Lee, Ji-young Hwang, Dae-Kyu Oh, Mee-Kyung Kee, Eunjung Oh, Jung-wook An, Jinhyun Kim, Heonsook Do, Hee-Jin Kim, Sung Soon Kim, Hwahyun Kim, Jeong-Gu Nam

Published in: BMC Infectious Diseases | Issue 1/2010

Login to get access

Abstract

Background

Although, in South Korea, human immunodeficiency virus/acquired immunodeficiency syndrome(HIV/AIDS) keeps increasing and tuberculosis(TB) burden is still significant, there have been few reports on TB/HIV cases. In this study, we investigated the burden and characteristics of TB/HIV patients in South Korea, an area with intermediate burden of TB and a low prevalent area with HIV/AIDS.

Methods

We identified patients with TB and cases with HIV between January 1 2001 and December 31 2005, from nationwide reporting system (TBnet and HIV/AIDS registry) through an electronic record linkage method. A questionnaire survey was also conducted and determined the rate of diagnosis of HIV among TB cases in public health units in 2005.

Results

The number of cases with both HIV and TB was 137 (0.07% among 197,562 TB cases) and the newly detected TB/HIV cases per 100,000 population was increasing annually: 2001, 0.025; 2002, 0.031; 2003, 0.025; 2004, 0.071; 2005, 0.095. Males between 20 and 59 years of age accounted for 87.6% of TB/HIV patients. Compared with patients with TB alone, those with TB/HIV had a higher percentage of extrapulmonary TB (8.0% vs 19.0%; p < 0.0001). The standardized prevalence ratio (SPR) of HIV among patients with TB was 18.46 (95% CI, 15.50-21.83). SPR of HIV among male TB patients aged 20-59 and extrapulmonary TB cases was 39.64 (95% CI, 32.87-47.40) and 43.21 (95% CI, 28.22-63.31) respectively. Through a questionnaire survey of public health units, six patients (0.08%) were confirmed as having HIV among 7,871 TB patients in public health centers in 2005, which is similar to the result from the study through nationwide reporting systems.

Conclusions

The prevalence rate of TB/HIV patients is still low but increasing in South Korea. Physicians should consider performing HIV tests among TB patients, especially in higher-risk groups, such as young males with extrapulmonary TB in South Korea.
Appendix
Available only for authorised users
Literature
1.
go back to reference World Health Organization: Global Tuberculosis Control: Surveillance, Planing, Financing: WHO report 2006. 2008, Geneva, Switzerland: World Health Organization World Health Organization: Global Tuberculosis Control: Surveillance, Planing, Financing: WHO report 2006. 2008, Geneva, Switzerland: World Health Organization
2.
go back to reference The Joint United Nations Programme on HIV/AIDS: AIDS epdemic update 2007. 2007, Geneva, Switzerland: Joint United Nations Programme on HIV/AIDS (UNAIDS) and World Health Organization (WHO) The Joint United Nations Programme on HIV/AIDS: AIDS epdemic update 2007. 2007, Geneva, Switzerland: Joint United Nations Programme on HIV/AIDS (UNAIDS) and World Health Organization (WHO)
3.
go back to reference Di Perri G, Cruciani M, Danzi MC, Luzzati R, De Checchi G, Malena M, Pizzighella S, Mazzi R, Solbiati M, Concia E, et al: Nosocomial epidemic of active tuberculosis among HIV-infected patients. Lancet. 1989, 2 (8678-8679): 1502-1504.PubMed Di Perri G, Cruciani M, Danzi MC, Luzzati R, De Checchi G, Malena M, Pizzighella S, Mazzi R, Solbiati M, Concia E, et al: Nosocomial epidemic of active tuberculosis among HIV-infected patients. Lancet. 1989, 2 (8678-8679): 1502-1504.PubMed
4.
go back to reference Raviglione MC, Harries AD, Msiska R, Wilkinson D, Nunn P: Tuberculosis and HIV: current status in Africa. AIDS. 1997, 11 (Suppl B): S115-123.PubMed Raviglione MC, Harries AD, Msiska R, Wilkinson D, Nunn P: Tuberculosis and HIV: current status in Africa. AIDS. 1997, 11 (Suppl B): S115-123.PubMed
5.
go back to reference Fitzgerald DW, Desvarieux M, Severe P, Joseph P, Johnson WD, Pape JW: Effect of post-treatment isoniazid on prevention of recurrent tuberculosis in HIV-1-infected individuals: a randomised trial. Lancet. 2000, 356 (9240): 1470-1474. 10.1016/S0140-6736(00)02870-1.CrossRefPubMed Fitzgerald DW, Desvarieux M, Severe P, Joseph P, Johnson WD, Pape JW: Effect of post-treatment isoniazid on prevention of recurrent tuberculosis in HIV-1-infected individuals: a randomised trial. Lancet. 2000, 356 (9240): 1470-1474. 10.1016/S0140-6736(00)02870-1.CrossRefPubMed
6.
go back to reference Dye C, Espinal MA, Watt CJ, Mbiaga C, Williams BG: Worldwide incidence of multidrug-resistant tuberculosis. J Infect Dis. 2002, 185 (8): 1197-1202. 10.1086/339818.CrossRefPubMed Dye C, Espinal MA, Watt CJ, Mbiaga C, Williams BG: Worldwide incidence of multidrug-resistant tuberculosis. J Infect Dis. 2002, 185 (8): 1197-1202. 10.1086/339818.CrossRefPubMed
7.
go back to reference Gandhi NR, Moll A, Sturm AW, Pawinski R, Govender T, Lalloo U, Zeller K, Andrews J, Friedland G: Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa. Lancet. 2006, 368 (9547): 1575-1580. 10.1016/S0140-6736(06)69573-1.CrossRefPubMed Gandhi NR, Moll A, Sturm AW, Pawinski R, Govender T, Lalloo U, Zeller K, Andrews J, Friedland G: Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa. Lancet. 2006, 368 (9547): 1575-1580. 10.1016/S0140-6736(06)69573-1.CrossRefPubMed
8.
go back to reference Madariaga MG, Lalloo UG, Swindells S: Extensively drug-resistant tuberculosis. Am J Med. 2008, 121 (10): 835-844. 10.1016/j.amjmed.2008.04.015.CrossRefPubMed Madariaga MG, Lalloo UG, Swindells S: Extensively drug-resistant tuberculosis. Am J Med. 2008, 121 (10): 835-844. 10.1016/j.amjmed.2008.04.015.CrossRefPubMed
9.
go back to reference Rosas-Taraco AG, Arce-Mendoza AY, Caballero-Olin G, Salinas-Carmona MC: Mycobacterium tuberculosis upregulates coreceptors CCR5 and CXCR4 while HIV modulates CD14 favoring concurrent infection. AIDS Res Hum Retroviruses. 2006, 22 (1): 45-51. 10.1089/aid.2006.22.45.CrossRefPubMed Rosas-Taraco AG, Arce-Mendoza AY, Caballero-Olin G, Salinas-Carmona MC: Mycobacterium tuberculosis upregulates coreceptors CCR5 and CXCR4 while HIV modulates CD14 favoring concurrent infection. AIDS Res Hum Retroviruses. 2006, 22 (1): 45-51. 10.1089/aid.2006.22.45.CrossRefPubMed
10.
go back to reference Nakata K, Rom WN, Honda Y, Condos R, Kanegasaki S, Cao Y, Weiden M: Mycobacterium tuberculosis enhances human immunodeficiency virus-1 replication in the lung. Am J Respir Crit Care Med. 1997, 155 (3): 996-1003.CrossRefPubMed Nakata K, Rom WN, Honda Y, Condos R, Kanegasaki S, Cao Y, Weiden M: Mycobacterium tuberculosis enhances human immunodeficiency virus-1 replication in the lung. Am J Respir Crit Care Med. 1997, 155 (3): 996-1003.CrossRefPubMed
11.
go back to reference Greenberg AE, Lucas S, Tossou O, Coulibaly IM, Coulibaly D, Kassim S, Ackah A, De Cock KM: Autopsy-proven causes of death in HIV-infected patients treated for tuberculosis in Abidjan, Cote d'Ivoire. AIDS. 1995, 9 (11): 1251-1254. 10.1097/00002030-199511000-00006.CrossRefPubMed Greenberg AE, Lucas S, Tossou O, Coulibaly IM, Coulibaly D, Kassim S, Ackah A, De Cock KM: Autopsy-proven causes of death in HIV-infected patients treated for tuberculosis in Abidjan, Cote d'Ivoire. AIDS. 1995, 9 (11): 1251-1254. 10.1097/00002030-199511000-00006.CrossRefPubMed
12.
go back to reference Cantwell MF, Binkin NJ: Tuberculosis in sub-Saharan Africa: a regional assessment of the impact of the human immunodeficiency virus and National Tuberculosis Control Program quality. Tuber Lung Dis. 1996, 77 (3): 220-225. 10.1016/S0962-8479(96)90004-0.CrossRefPubMed Cantwell MF, Binkin NJ: Tuberculosis in sub-Saharan Africa: a regional assessment of the impact of the human immunodeficiency virus and National Tuberculosis Control Program quality. Tuber Lung Dis. 1996, 77 (3): 220-225. 10.1016/S0962-8479(96)90004-0.CrossRefPubMed
13.
go back to reference Quigley MA, Mwinga A, Hosp M, Lisse I, Fuchs D, Porter JDH, Godfrey-Faussett P: Long-term effect of preventive therapy for tuberculosis in a cohort of HIV-infected Zambian adults. AIDS. 2001, 15 (2): 215-222. 10.1097/00002030-200101260-00011.CrossRefPubMed Quigley MA, Mwinga A, Hosp M, Lisse I, Fuchs D, Porter JDH, Godfrey-Faussett P: Long-term effect of preventive therapy for tuberculosis in a cohort of HIV-infected Zambian adults. AIDS. 2001, 15 (2): 215-222. 10.1097/00002030-200101260-00011.CrossRefPubMed
14.
go back to reference Girardi E, Antonucci G, Vanacore P, Libanore M, Errante I, Matteelli A, Ippolito G: Impact of combination antiretroviral therapy on the risk of tuberculosis among persons with HIV infection. AIDS. 2000, 14 (13): 1985-1991. 10.1097/00002030-200009080-00015.CrossRefPubMed Girardi E, Antonucci G, Vanacore P, Libanore M, Errante I, Matteelli A, Ippolito G: Impact of combination antiretroviral therapy on the risk of tuberculosis among persons with HIV infection. AIDS. 2000, 14 (13): 1985-1991. 10.1097/00002030-200009080-00015.CrossRefPubMed
15.
go back to reference Jones JL, Hanson DL, Dworkin MS, DeCock KM: HIV-associated tuberculosis in the era of highly active antiretroviral therapy. The Adult/Adolescent Spectrum of HIV Disease Group. Int J Tuberc Lung Dis. 2000, 4 (11): 1026-1031.PubMed Jones JL, Hanson DL, Dworkin MS, DeCock KM: HIV-associated tuberculosis in the era of highly active antiretroviral therapy. The Adult/Adolescent Spectrum of HIV Disease Group. Int J Tuberc Lung Dis. 2000, 4 (11): 1026-1031.PubMed
16.
go back to reference World Health Organization: Strategic Framework to Decrease Burden of TB/HIV. 2002, Geneva, Switzerland: World Health Organization World Health Organization: Strategic Framework to Decrease Burden of TB/HIV. 2002, Geneva, Switzerland: World Health Organization
17.
go back to reference World Health Organization: Interim Policy on Collaborative TB/HIV activities. 2004, Geneva, Switzerland: World Health Organization World Health Organization: Interim Policy on Collaborative TB/HIV activities. 2004, Geneva, Switzerland: World Health Organization
18.
go back to reference Grimes DA, Schulz KF: Uses and abuses of screening tests. Lancet. 2002, 359 (9309): 881-884. 10.1016/S0140-6736(02)07948-5.CrossRefPubMed Grimes DA, Schulz KF: Uses and abuses of screening tests. Lancet. 2002, 359 (9309): 881-884. 10.1016/S0140-6736(02)07948-5.CrossRefPubMed
19.
go back to reference Harris T, Panaro L, Phypers M, Choudhri Y, Archibald CP: HIV Testing among Canadian Tuberculosis Cases from 1997 to 1998. Can J Infect Dis Med Microbiol. 2006, 17 (3): 165-168.PubMedPubMedCentral Harris T, Panaro L, Phypers M, Choudhri Y, Archibald CP: HIV Testing among Canadian Tuberculosis Cases from 1997 to 1998. Can J Infect Dis Med Microbiol. 2006, 17 (3): 165-168.PubMedPubMedCentral
21.
go back to reference The Joint United Nations Programme on HIV/AIDS: 2006 Report on the Global AIDS Epidemic. 2006, Geneva, Switzerland: World Health Organization The Joint United Nations Programme on HIV/AIDS: 2006 Report on the Global AIDS Epidemic. 2006, Geneva, Switzerland: World Health Organization
22.
go back to reference Hong YP, Kim SJ, Lew WJ, Lee EK, Han YC: The seventh nationwide tuberculosis prevalence survey in Korea, 1995. Int J Tuberc Lung Dis. 1998, 2 (1): 27-36.PubMed Hong YP, Kim SJ, Lew WJ, Lee EK, Han YC: The seventh nationwide tuberculosis prevalence survey in Korea, 1995. Int J Tuberc Lung Dis. 1998, 2 (1): 27-36.PubMed
24.
go back to reference Lindholm J, Juul S, Jorgensen JO, Astrup J, Bjerre P, Feldt-Rasmussen U, Hagen C, Jorgensen J, Kosteljanetz M, Kristensen L, et al: Incidence and late prognosis of cushing's syndrome: a population-based study. J Clin Endocrinol Metab. 2001, 86: 117-123. 10.1210/jc.86.1.117.PubMed Lindholm J, Juul S, Jorgensen JO, Astrup J, Bjerre P, Feldt-Rasmussen U, Hagen C, Jorgensen J, Kosteljanetz M, Kristensen L, et al: Incidence and late prognosis of cushing's syndrome: a population-based study. J Clin Endocrinol Metab. 2001, 86: 117-123. 10.1210/jc.86.1.117.PubMed
25.
go back to reference Ohsawa M, Kato K, Itai K, Tanno K, Fujishima Y, Konda R, Okayama A, Abe K, Suzuki K, Nakamura M, et al: Standardized Prevalence Ratios for Chronic Hepatitis C Virus Infection Among Adult Japanese Hemodialysis Patients. J Epidemiol. 2009, 20 (1): 30-39. 10.2188/jea.JE20090043.CrossRefPubMed Ohsawa M, Kato K, Itai K, Tanno K, Fujishima Y, Konda R, Okayama A, Abe K, Suzuki K, Nakamura M, et al: Standardized Prevalence Ratios for Chronic Hepatitis C Virus Infection Among Adult Japanese Hemodialysis Patients. J Epidemiol. 2009, 20 (1): 30-39. 10.2188/jea.JE20090043.CrossRefPubMed
27.
go back to reference Corbett EL, Watt CJ, Walker N, Maher D, Williams BG, Raviglione MC, Dye C: The growing burden of tuberculosis: global trends and interactions with the HIV epidemic. Arch Intern Med. 2003, 163 (9): 1009-1021. 10.1001/archinte.163.9.1009.CrossRefPubMed Corbett EL, Watt CJ, Walker N, Maher D, Williams BG, Raviglione MC, Dye C: The growing burden of tuberculosis: global trends and interactions with the HIV epidemic. Arch Intern Med. 2003, 163 (9): 1009-1021. 10.1001/archinte.163.9.1009.CrossRefPubMed
28.
go back to reference Faggiano F, Vigna-Taglianti FD, Versino E, Salamina G, Bugiani M: Tuberculosis incidence in Turin, Italy, 1973-1999. Int J Tuberc Lung Dis. 2004, 8 (2): 171-179.PubMed Faggiano F, Vigna-Taglianti FD, Versino E, Salamina G, Bugiani M: Tuberculosis incidence in Turin, Italy, 1973-1999. Int J Tuberc Lung Dis. 2004, 8 (2): 171-179.PubMed
29.
go back to reference Martin V, Cayla JA, Bolea A, Castilla J: Mycobacterium tuberculosis and human immunodeficiency virus co-infection in intravenous drug users on admission to prison. Int J Tuberc Lung Dis. 2000, 4 (1): 41-46.PubMed Martin V, Cayla JA, Bolea A, Castilla J: Mycobacterium tuberculosis and human immunodeficiency virus co-infection in intravenous drug users on admission to prison. Int J Tuberc Lung Dis. 2000, 4 (1): 41-46.PubMed
30.
go back to reference Pablos-Mendez A, Blustein J, Knirsch CA: The role of diabetes mellitus in the higher prevalence of tuberculosis among Hispanics. Am J Public Health. 1997, 87 (4): 574-579. 10.2105/AJPH.87.4.574.CrossRefPubMedPubMedCentral Pablos-Mendez A, Blustein J, Knirsch CA: The role of diabetes mellitus in the higher prevalence of tuberculosis among Hispanics. Am J Public Health. 1997, 87 (4): 574-579. 10.2105/AJPH.87.4.574.CrossRefPubMedPubMedCentral
31.
go back to reference Moss AR, Hahn JA, Tulsky JP, Daley CL, Small PM, Hopewell PC: Tuberculosis in the homeless. A prospective study. Am J Respir Crit Care Med. 2000, 162 (2 Pt 1): 460-464.CrossRefPubMed Moss AR, Hahn JA, Tulsky JP, Daley CL, Small PM, Hopewell PC: Tuberculosis in the homeless. A prospective study. Am J Respir Crit Care Med. 2000, 162 (2 Pt 1): 460-464.CrossRefPubMed
32.
go back to reference Smith DK, Gwinn M, Selik RM, Miller KS, Dean-Gaitor H, Ma'at PI, De Cock KM, Gayle HD: HIV/AIDS among African Americans: progress or progression?. AIDS. 2000, 14 (9): 1237-1248. 10.1097/00002030-200006160-00022.CrossRefPubMed Smith DK, Gwinn M, Selik RM, Miller KS, Dean-Gaitor H, Ma'at PI, De Cock KM, Gayle HD: HIV/AIDS among African Americans: progress or progression?. AIDS. 2000, 14 (9): 1237-1248. 10.1097/00002030-200006160-00022.CrossRefPubMed
33.
go back to reference Centers for Disease Control and Prevention: Reported Tuberculosis in the United States, 1999. 2000, Atlanta: US Dept of Health and Human Services Centers for Disease Control and Prevention: Reported Tuberculosis in the United States, 1999. 2000, Atlanta: US Dept of Health and Human Services
34.
go back to reference Sharma SK, Mohan A, Kadhiravan T: HIV-TB co-infection: epidemiology, diagnosis & management. Indian J Med Res. 2005, 121 (4): 550-567.PubMed Sharma SK, Mohan A, Kadhiravan T: HIV-TB co-infection: epidemiology, diagnosis & management. Indian J Med Res. 2005, 121 (4): 550-567.PubMed
35.
go back to reference Lew WJ, Lee EG, Bai JY, Kim HJ, Bai GH, Ahn DI, Lee JK, Kim SJ: An Internet-based surveillance system for tuberculosis in Korea. Int J Tuberc Lung Dis. 2006, 10 (11): 1241-1247.PubMed Lew WJ, Lee EG, Bai JY, Kim HJ, Bai GH, Ahn DI, Lee JK, Kim SJ: An Internet-based surveillance system for tuberculosis in Korea. Int J Tuberc Lung Dis. 2006, 10 (11): 1241-1247.PubMed
Metadata
Title
The burden and characteristics of tuberculosis/human immunodeficiency virus (TB/HIV) in South Korea: a study from a population database and a survey
Authors
Chang-Hoon Lee
Ji-young Hwang
Dae-Kyu Oh
Mee-Kyung Kee
Eunjung Oh
Jung-wook An
Jinhyun Kim
Heonsook Do
Hee-Jin Kim
Sung Soon Kim
Hwahyun Kim
Jeong-Gu Nam
Publication date
01-12-2010
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2010
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/1471-2334-10-66

Other articles of this Issue 1/2010

BMC Infectious Diseases 1/2010 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.